Skip to main content
Premium Trial:

Request an Annual Quote

LA Investment Firm Helping Chinese Genomics Firm Land US Pharma Deals

NEW YORK, May 28 (GenomeWeb News) - NewCap Partners, a Los Angeles-based boutique investment-banking company, is helping Shanghai Genomics forge contract research alliances with US drug makers, according to a report on Forbes.com today.

 

Shanghai Genomics, based in Shanghai, China,offers the following services, according to its website: siRNA design and synthesis; protein-protein interaction screening; and gene-expression studies using Q-PCR or IHC. The firm employs 70 person people.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.